Degenerative Process Articles & Analysis

2 news found

CELLVIE featured in Biocentury`s Emerging Company Profile

"Interestingly, when you reintroduce the blood flow, there's a the second wave of cell death, as the oxygen streaming into the cells can no longer be processed by the impaired mitochondria. So, to treat ischemia-reperfusion injury, one must treat that mitochondria damage," he added. ...

Sep. 27, 2021

Bycellvie Inc.

Neuraptive Therapeutics Announces FDA Clearance of IND Application for NTX-001, a Novel Approach for the Treatment of Patients with Peripheral Nerve Injuries

We believe that NTX-001 has the potential to diminish or prevent this degenerative process so that nerves recover more quickly, and patients can avoid disabilities that commonly result from these types of nerve injuries," said Ivan Gergel, MD, Executive Chairman of the Board of Neuraptive. ...

Apr. 28, 2020

ByNeuraptive Therapeutics, Inc.

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you